Back to Search
Start Over
Confounding and missing data in cost-effectiveness analysis: comparing different methods
- Source :
- Health Economics Review
- Publication Year :
- 2013
- Publisher :
- Springer Science and Business Media LLC, 2013.
-
Abstract
- Introduction Common approaches in cost-effectiveness analyses do not adjust for confounders. In nonrandomized studies this can result in biased results. Parametric models such as regression models are commonly applied to adjust for confounding, but there are several issues which need to be accounted for. The distribution of costs is often skewed and there can be a considerable proportion of observations of zero costs, which cannot be well handled using simple linear models. Associations between costs and effectiveness cannot usually be explained using observed background information alone, which also requires special attention in parametric modeling. Furthermore, in longitudinal panel data, missing observations are a growing problem also with nonparametric methods when cumulative outcome measures are used. Methods We compare two methods, which can handle the aforementioned issues, in addition to the standard unadjusted bootstrap techniques for assessing cost-effectiveness in the Helsinki Psychotherapy Study based on five repeated measurements of the Global Severity Index (SCL-90-GSI) and direct costs during one year of follow-up in two groups defined by the Defence Style Questionnaire (DSQ) at baseline. The first method models cumulative costs and effectiveness using generalized linear models, multiple imputation and bootstrap techniques. The second method deals with repeated measurement data directly using a hierarchical two-part logistic and gamma regression model for costs, a hierarchical linear model for effectiveness, and Bayesian inference. Results The adjustment for confounders mitigated the differences of the DSQ groups. Our method, based on Bayesian inference, revealed the unexplained association of costs and effectiveness. Furthermore, the method also demonstrated strong heteroscedasticity in positive costs. Conclusions Confounders should be accounted for in cost-effectiveness analyses, if the comparison groups are not randomized. JEL classification C1; C3; I1
- Subjects :
- Generalized linear model
Heteroscedasticity
Predictive margins
Bayesian inference
two-part model
03 medical and health sciences
Indirect costs
C1
0302 clinical medicine
I1
ddc:330
Econometrics
Medicine
C3
Confounders
business.industry
Research
Cost-effectiveness analysis
030503 health policy & services
Health Policy
Multilevel model
cost-effectiveness analysis
Nonparametric statistics
Linear model
clinical trial
Regression analysis
predictive margins
confounders
Missing data
030227 psychiatry
Clinical trial
Two-part model
0305 other medical science
business
Subjects
Details
- ISSN :
- 21911991
- Volume :
- 3
- Database :
- OpenAIRE
- Journal :
- Health Economics Review
- Accession number :
- edsair.doi.dedup.....893e66f1c572c384a1d1e6ee84df063b